In a report released today, Bill Kerr from TD Cowen maintained a Buy rating on Chewy (CHWY – Research Report), with a price target of $45.00.

CRISPR Therapeutics (NASDAQ:CRSP) received an upgrade in its stock rating by analysts at TD Cowen, changing from Sell to Hold, while maintaining a price target of $35.00. The revision in the rating ...

TD Cowen analyst Moshe Orenbuch maintained a Hold rating on Bread Financial Holdings (BFH – Research Report) today and set a price target of ...

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities ...

CACI International Inc (NYSE: CACI) announced today that it will participate in the TD Cowen 46th Annual Aerospace ... that term is defined in the Private Securities Litigation Reform Act of ...

Enphase Energy (NASDAQ:ENPH – Get Free Report) had its price objective cut by analysts at TD Cowen from $120.00 to ... during the last quarter. Mizuho Securities USA LLC boosted its stake ...

Fintel reports that on January 17, 2025, TD Cowen upgraded their outlook for Salesforce (LSE:0QYJ) from Hold to Buy. There are 4,209 funds or institutions reporting positions in Salesforce.

TD Cowen upgraded Salesforce's (NYSE:CRM) rating to Buy from Hold and raised the price target to $400 from $380. Shares of Salesforce rose about 2% on Friday. Analysts led by Derrick Wood said ...

Investing.com-- TD Cowen analysts have upgraded Salesforce Inc's (NYSE:CRM) rating and raised their price target, citing optimism over the company’s role in the expanding "Agentic AI" cycle. Analysts ...

Investing.com -- TD Cowen upgraded SAP SE ADR (NYSE:SAP) stock to Buy from Hold and raised its price target to $305 from $240. Analysts at the bank cited SAP's resilient stock appreciation and ...

Investing.com -- TD Cowen upgraded SAP SE ADR (NYSE:SAP) stock to Buy from Hold and raised its price target to $305 from $240. Analysts at the bank cited SAP's resilient stock appreciation and growth ...